Sociedades Científicas
Sociedades y Asociaciones Científicas
- 1982-: Osaka University Psychiatric Association.
- 1983: International Association of Social Psychiatry.
- 1983-84: Japanese Branch of the International Association for Social Psychiatry.
- 1983-: The Japanese Society of Endocrinology.
- 1983-: The Japanese Neurochemical Society.
- 1985-: The Japanese Neuroscience Society.
- 1985-: The Japanese Society of Pharmacology.
- 1985-: European Neuroendocrine Association.
- 1985-: International Society of Psychoneuroendocrinology.
- 1985-: The Japanese Society of Geriatrics.
- 1985-: European Histamine Research Society.
- 1987-: Sociedad Española de Endocrinología.
- 1989-: Asociación Gallega de Psiquiatría.
- 1989-: European Neuroscience Association.
- 1989-: European College of Neuropsychopharmacology.
- 1989-: Sociedad Española de Neurociencias.
- 1990-: International Psychogeriatric Association.
- 1992-: New York Academy of Sciences.
- 1992-: American Association for the Advancement of Science.
- 1993-: Asociación Española de Neurogerontología y Neurogeriatría.
- 1995-: American Association for Clinical Chemistry.
- 1997: Sociedad de Neurociencias de Cuba.
Sección de Demencias y Enfermedad de Alzheimer. - 1997-: American Society of Hispanic Psychiatry.
- 2001-: The Japanese Psychogeriatric Society.
- 2001-: The American Geriatrics Society.
- 2001-: Drug Information Association.
- 2002-: International Society of Lyophilization-Freeze Drying, Inc.
- 2002-: Human Genome Variation Society.
- 2004-: The American Geriatrics Society. AGS ID: 053617.
- 2005-: Sociedad Española de Medicina Genómica.
- 2005-: Sociedad Española de Nutracéutica Médica.
- 2007-: World Association for Cancer Research.
- 2008-: World Association of Genomic Medicine.
- International Alzheimer’s disease Advisory Board.
Tacrine (Parke-Davis)(1993-). - Chairman, First International Course on Neurogerontology and Psychogeriatrics.
EUROESPES Foundation, La Coruña (1993-). - International Scientific Advisory Committee.
Fourth International Conference on Alzheimer’s Disease and Related Disorders, Minneapolis (1993-1994). - International Organizing Committee.
International Springfield Committee on Advances in Alzheimer therapy, Springfield, IL (1993-1994). - European Scientific Committee of Alzheimer’s disease.
S-12024, Servier, Paris (1992-). - Faculty Member, The Karolinska Institute Postgraduate Education Series, Stockholm.
(1994-). - International Scientific Advisory Committee for the Evaluation Program for Reminyl (Sabeluzole) in Alzheimer’s Disease.
Sabeluzole, Janssen, New York (1995-). - International Scientific Advisory Committee for Assessing Therapeutic Response in Alzheimer’s Disease. Quality of Life.
Xanomeline, Eli Lilly, Paris (1995-). - International Working Group on Harmonization of Dementia Drug Guidelines.
USA (1995-). - International Organizing Committee. Fourth International Nice/Springfield Symposium on Alzheimer Therapy.
Nice/Springfield (1995-1996). - International Scientific Advisory Committee for the Fifth International Conference on Alzheimer’s Disease and Related Disorders.
Osaka (1995-1996). - European Coordinator of S-20298/Phase IIb-Alzheimer, IRIS, Paris (3.1.1996).
- European Concerted Action on Pick’s Disease (ECAPD) Consortium (1997-1998).
- Novartis Gerontological Foundation (1998).
- Comité Consellería Industria/Xunta de Galicia-IGAPE-AFEG-COTEC de Innovación Tecnológica (1998).
- International Organizing Committee. Fifth International Geneva/Springfield Symposium on Advances in Alzheimer Therapy, Ginebra (1997).
- International Working Group on Prevention of Alzheimer’s Disease.
Ronald & Nancy Reagan Institute of the Alzheimer’s Association Ginebra (1998). - International Committee. 6th International Conference on Alzheimer’s Disease and Related Disorders, Amsterdam (1998).
- International Organizing Committee. Sixth International Stockholm/Springfield Symposium on Advances in Alzheimer Therapy. Stockholm (1999-2006).
- International Advisory Board. Celocoxib. Searle/Monsanto (1998-1999).
- International Advisory Board. FK960. Fujisawa (1999-2001).
- Comité de Honor. Fundación Humanismo y Ciencia. Madrid (2000).
- Alzheimer’s Disease-Advisory Meeting. GlaxoSmithKline (2002).
- Sociedad Estatal para Exposiciones Internacionales (SEEI) (2003-2005).
- Internationale Stichting Alzheimer Onderzoek (ISAO) (2003).
- The Council of Heart and Life Sciences, The Netherlands Government (2004).
- Medical Research Council, United Kingdom (2004).
- Genome Canada (2005).
- Karolinska Institutet (2005).
- Research into Aging. Help the Aged, United Kingdom (2005).
- Sociedad Iberoamericana de la Información Científica (2005).
- Michael Smith Foundation for Health Research, Canadá (2005).
- Expo 2005 Aichi. Pabellón de España. Comisión España Aichi 2005 (Japón).
- International Psychogeriatric Association (IPA).
IPA 2007 Osaka Silver Congress (2007). - Presidente, Comité Científico, World Association for Cancer Research (2007).
- Takeda Pharmaceutical Industry. New Technologies/Methodologies for the Development of Disease-Modifying Compounds for Alzheimer’s Disease and Parkinson’s Disease, Miami, USA (2008).
- Novartis Consultant, Kyoto (2013).